Trovagene (TROV) Announces $1.5 Million Equity Investment at Premium to Market from Lincoln Park Capital – StreetInsider.com

Trovagene (TROV) Announces $1.5 Million Equity Investment at Premium to Market from Lincoln Park Capital  StreetInsider.com

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division …

>